Skip to Main Content
Michelle Glasky Bergman, Ph.D.

Dr. Michelle Glasky Bergman is a patent agent in the firm’s Orange County office and works with attorneys and clients in the creation and maintenance of IP portfolios including domestic and international patent prosecution and portfolio management and manages client relationships across technologies. Dr. Michelle represents independent inventors, small companies, and large publically-traded companies in the intellectual property field.

Dr. Michelle has extensive experience in a wide breadth of technologies including small molecules and biologics for the therapy, prevention and diagnosis of disease, vaccines, biotechnology, diagnostics, cosmetics, dietary supplements, and regenerative stem cell technologies.

Prior to joining K&L Gates, Dr. Michelle was an executive at a publicly-traded pharmaceutical company managing preclinical and clinical research as well as managing a robust patent portfolio and has extensive experience working on the scientific and managerial sides of the life sciences industry. Dr. Michelle also managed an academic laboratory and associated million dollar small business for a university professor.

  • Mentor, University of California, Irvine School of Biomedical Sciences
  • Education and Advocacy Committee of the Crohn’s and Colitis Foundation
  • Wieland S., Glasky M.S., Glasky A.J. “Neotrofin: Regenerative medicine in the treatment of Alzheimer’s disease.” In: Research & Practice in Alzheimer’s Disease. 5:187-92, 2001.
  • Hu P., Hornick J.L., Glasky M.S., Yun A., Alauddin M.M., Anderson P., Khawli L.A. and Epstein A.L. “A chimeric Lym-1/interleukin-2 fusion protein for increasing vascular permeability and antibody uptake in human lymphomas,” Cancer Research 56:4998-5004, 1996.
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel